CD223 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD223 monoclonal antibodies for advanced research in immunology and cell biology. CD223 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD223, also known as LAG-3, is a critical immune checkpoint protein that plays a significant role in regulating T cell activation and maintaining immune homeostasis. By inhibiting the proliferation and function of T cells, CD223 is essential in preventing autoimmunity and modulating immune responses during infections and cancer. Understanding CD223 function is crucial for developing therapeutic strategies aimed at enhancing anti-tumor immunity and improving vaccine efficacy. CD223 research has revealed important insights into immune system regulation and potential therapeutic applications. Ongoing studies continue to uncover new aspects of CD223's role in immune responses and disease progression. Research utilizing CD223 monoclonal antibodies has led to significant breakthroughs in understanding immune checkpoint regulation. Santa Cruz Biotechnology monoclonal antibodies for CD223 support researchers worldwide in advancing our understanding of immune system regulation and developing new therapeutic approaches.